Retinitis pigmentosa
Conditions
Interventions
None listed
Sponsors
Santen Pharmaceutical Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who have been diagnosed with retinitis pigmentosa in both eyes
Exclusion criteria
Exclusion criteria: Any decision by the Investigator to terminate a subject in screening
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual function (Corrected visual acuity, Visual field, etc.) | — |
Countries
Japan
Contacts
Public ContactYuki Togashi
Santen Pharmaceutical Co., Ltd. Ophthalmology Innovation Center
Outcome results
None listed